Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09578-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Muinah Adenike Fowora und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria. muinahj@yahoo.com. Hauptthemen laut MEDLINE: COVID-19, Staphylococcal Infections, Staphylococcus aureus, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Nigerian Institute of Medical Research.
Abstract (Originalsprache)
BACKGROUND: Staphylococcus aureus (S. aureus) associated with COVID-19 has not been well documented. This cross-sectional study evaluated the association between nasal S. aureus carriage and COVID-19. METHODS AND RESULTS: Nasopharyngeal samples were collected from 391 participants presenting for COVID-19 test in Lagos, Nigeria, and S. aureus was isolated from the samples. Antimicrobial susceptibility test was done by disc diffusion method. All S. aureus isolates were screened for the presence of mecA, panton-valentine leucocidin (PVL) and toxic shock syndrome toxin (TSST) virulence genes by polymerase chain reaction. Staphylococcal protein A (spa) typing was conducted for all the isolates. Participants with COVID-19 had double the prevalence of S. aureus (42.86%) compared to those who tested negative (20.54%). A significant association was seen between S. aureus nasal carriage and COVID-19 (p = 0.004). Antimicrobial sensitivity results showed resistance to oxacillin (100%), cefoxitin (53%), and vancomycin (98.7%). However, only 41% of the isolates harbored the mecA gene, with SCCmecV being the most common SCCmec type. There was no association between the carriage of virulence genes and COVID-19. A total of 23 Spa types were detected, with t13249 and t095 being the two most common spa types. CONCLUSION: This study examined the association between nasal S. aureus carriage and SARS-COV-2 infection. Further research is required to fully explore the implications of S. aureus co-infection with COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria. muinahj@yahoo.com.
- Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria.
- FOWM Biotechnology Laboratories, Lagos, Nigeria.
- Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
- Department of Science Laboratory Technology, Faculty of Science, Lagos State University, Lagos, Nigeria.
- Infectious Diseases Hospital, Lagos, Nigeria.
Förderung
- Nigerian Institute of Medical Research
Zitieren
APA
Fowora, M. A., Aiyedogbon, A., Omolopo, I., Tajudeen, A. O., Onyeaghasiri, F., Edu-Muyideen, I., Olanlege, A. O., Abioye, A., Bamidele, T. A., Raheem, T., Adesesan, A., Iwalokun, B., & Salako, B. L. (2024). Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09578-3
Vancouver
Fowora MA, Aiyedogbon A, Omolopo I, Tajudeen AO, Onyeaghasiri F, Edu-Muyideen I, et al. Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09578-3
BibTeX
@article{Fowora2024,
author = {Fowora, Muinah Adenike and Aiyedogbon, Adenike and Omolopo, Ibilola and Tajudeen, Ahmed Oluwasegun and Onyeaghasiri, Faustina and Edu-Muyideen, Idowu and Olanlege, Abdul-Lateef Olatunde and Abioye, Aminah and Bamidele, Tajudeen Akanji and Raheem, Toyosi and Adesesan, Adesegun and Iwalokun, Bamidele and Salako, Babatunde Lawal},
title = {Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09578-3}
}
EUVIMED